- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
- NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
- NexImmune Announces 1-for-25 Reverse Stock Split
- NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
- NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
More ▼
Key statistics
On Friday, Neximmune Inc (NEXI:NAQ) closed at 2.37, 89.58% above the 52 week low of 1.25 set on Nov 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.42 |
---|---|
High | 2.46 |
Low | 2.35 |
Bid | 2.37 |
Offer | 2.48 |
Previous close | 2.48 |
Average volume | 9.29k |
---|---|
Shares outstanding | 1.37m |
Free float | 1.14m |
P/E (TTM) | -- |
Market cap | 3.25m USD |
EPS (TTM) | -24.16 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 20:56 BST.
More ▼